GL261小鼠胶质细胞瘤

在20世纪90年代中期从Gl261肿瘤建立了体外生长细胞培养，该肿瘤于1939年通过颅内注射3-甲基胆蒽到C57BL/6小鼠中诱导，随后通过在同基因小鼠系中的连续移植维持；文献中描述细胞携带TP53和KRAS突变

组织来源/Tissue and Cell Type ：胶质瘤

形态/Morphology ：成纤维细胞样，贴壁生长

培养基和添加剂/Complete Growth Medium and Culture Conditions:

90%DMEM(MD0100)+10%胎牛血清(SD0200)+G/A (SD0038)

完全培养基：DMEM完全培养基（货号：MD0101）

气相：空气，95%；二氧化碳，5%。 温度：37摄氏度。

冻存条件：基础培养基+5%DMSO+20%FBS(SD0200)

完全冻存液：免程序降温细胞冻存液（低血清）(SD0001)

注意事项：此产品仅供科研使用

PubMed=16734735; DOI=10.1111/j.1349-7006.2006.00208.x
Szatmari T., Lumniczky K., Desaknai S., Trajcevski S., Hidvegi E.J., Hamada H., Safrany G.
Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy.
Cancer Sci. 97:546-553(2006)

PubMed=23248259; DOI=10.4049/jimmunol.1201557
Ohlfest J.R., Andersen B.M., Litterman A.J., Xia J.-Z., Pennell C.A., Swier L.E., Salazar A.M., Olin M.R.
Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model.
J. Immunol. 190:613-620(2013)

PubMed=23686484; DOI=10.4049/jimmunol.1203539
Litterman A.J., Zellmer D.M., Grinnen K.L., Hunt M.A., Dudek A.Z., Salazar A.M., Ohlfest J.R.
Profound impairment of adaptive immune responses by alkylating chemotherapy.
J. Immunol. 190:6259-6268(2013)

PubMed=25894527; DOI=10.1371/journal.pone.0121314
Bausch-Fluck D., Hofmann A., Bock T., Frei A.P., Cerciello F., Jacobs A., Moest H., Omasits U., Gundry R.L., Yoon C., Schiess R., Schmidt A., Mirkowska P., Hartlova A., Van Eyk J.E., Bourquin J.-P., Aebersold R., Boheler K.R., Zandstra P.W., Wollscheid B.
A mass spectrometric-derived cell surface protein atlas.
PLoS ONE 10:E0121314-E0121314(2015)

PubMed=30084848; DOI=10.1038/sdata.2018.157
Schuster H., Shao W.-G., Weiss T., Pedrioli P.G.A., Roth P., Weller M., Campbell D.S., Deutsch E.W., Moritz R.L., Planz O., Rammensee H.-G., Aebersold R., Caron E.
A tissue-based draft map of the murine MHC class I immunopeptidome.
Sci. Data 5:180157-180157(2018)

PubMed=30524896; DOI=10.1080/2162402X.2018.1501137
Genoud V., Marinari E., Nikolaev S.I., Castle J.C., Bukur V., Dietrich P.-Y., Okada H., Walker P.R.
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models.
OncoImmunology 7:e1501137.1-e1501137.10(2018)